These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 34279934)

  • 21. Cyclooxygenase/lipoxygenase shunting lowers the anti-cancer effect of cyclooxygenase-2 inhibition in colorectal cancer cells.
    Ganesh R; Marks DJ; Sales K; Winslet MC; Seifalian AM
    World J Surg Oncol; 2012 Sep; 10():200. PubMed ID: 23013454
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclooxygenase-2 inhibitors in colorectal cancer prevention: point.
    Arber N
    Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):1852-7. PubMed ID: 18708371
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery of novel hybrids of diaryl-1,2,4-triazoles and caffeic acid as dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase for cancer therapy.
    Cai H; Huang X; Xu S; Shen H; Zhang P; Huang Y; Jiang J; Sun Y; Jiang B; Wu X; Yao H; Xu J
    Eur J Med Chem; 2016 Jan; 108():89-103. PubMed ID: 26638042
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibitory Effects of Culinary Herbs and Spices on the Growth of HCA-7 Colorectal Cancer Cells and Their COX-2 Expression.
    Jaksevicius A; Carew M; Mistry C; Modjtahedi H; Opara EI
    Nutrients; 2017 Sep; 9(10):. PubMed ID: 28934138
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Celecoxib prevents tumor growth in vivo without toxicity to normal gut: lack of correlation between in vitro and in vivo models.
    Williams CS; Watson AJ; Sheng H; Helou R; Shao J; DuBois RN
    Cancer Res; 2000 Nov; 60(21):6045-51. PubMed ID: 11085526
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery of small molecule acting as multitarget inhibitor of colorectal cancer by simultaneous blocking of the key COX-2, 5-LOX and PIM-1 kinase enzymes.
    El-Miligy MMM; Al-Kubeisi AK; El-Zemity SR; Nassra RA; Abu-Serie MM; Hazzaa AA
    Bioorg Chem; 2021 Oct; 115():105171. PubMed ID: 34303896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemopreventive Efficacy of the Cyclooxygenase-2 (Cox-2) Inhibitor, Celecoxib, Is Predicted by Adenoma Expression of Cox-2 and 15-PGDH.
    Wang J; Cho NL; Zauber AG; Hsu M; Dawson D; Srivastava A; Mitchell-Richards KA; Markowitz SD; Bertagnolli MM
    Cancer Epidemiol Biomarkers Prev; 2018 Jul; 27(7):728-736. PubMed ID: 29769213
    [No Abstract]   [Full Text] [Related]  

  • 28. Cyclooxygenase-2 inhibitors in lung cancer treatment: Bench to bed.
    Liu R; Xu KP; Tan GS
    Eur J Pharmacol; 2015 Dec; 769():127-33. PubMed ID: 26548623
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stable and sustained release liposomal formulations of celecoxib: In vitro and in vivo anti-tumor evaluation.
    Matbou Riahi M; Sahebkar A; Sadri K; Nikoofal-Sahlabadi S; Jaafari MR
    Int J Pharm; 2018 Apr; 540(1-2):89-97. PubMed ID: 29371019
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis, antitumor activity, and molecular docking study of 2-cyclopentyloxyanisole derivatives: mechanistic study of enzyme inhibition.
    El-Husseiny WM; El-Sayed MA; El-Azab AS; AlSaif NA; Alanazi MM; Abdel-Aziz AA
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):744-758. PubMed ID: 32183576
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New nimesulide derivatives with amide/sulfonamide moieties: Selective COX-2 inhibition and antitumor effects.
    Güngör T; Ozleyen A; Yılmaz YB; Siyah P; Ay M; Durdağı S; Tumer TB
    Eur J Med Chem; 2021 Oct; 221():113566. PubMed ID: 34077833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design, synthesis and biological evaluation of novel indanone containing spiroisoxazoline derivatives with selective COX-2 inhibition as anticancer agents.
    Abolhasani H; Zarghi A; Komeili Movahhed T; Abolhasani A; Daraei B; Dastmalchi S
    Bioorg Med Chem; 2021 Feb; 32():115960. PubMed ID: 33477020
    [TBL] [Abstract][Full Text] [Related]  

  • 33. mTOR signaling is involved in indomethacin and nimesulide suppression of colorectal cancer cell growth via a COX-2 independent pathway.
    Zhang YJ; Bao YJ; Dai Q; Yang WY; Cheng P; Zhu LM; Wang BJ; Jiang FH
    Ann Surg Oncol; 2011 Feb; 18(2):580-8. PubMed ID: 20803081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of 11beta-hydroxysteroid dehydrogenase type II selectively blocks the tumor COX-2 pathway and suppresses colon carcinogenesis in mice and humans.
    Zhang MZ; Xu J; Yao B; Yin H; Cai Q; Shrubsole MJ; Chen X; Kon V; Zheng W; Pozzi A; Harris RC
    J Clin Invest; 2009 Apr; 119(4):876-85. PubMed ID: 19307727
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suppression of intestinal polyps in Msh2-deficient and non-Msh2-deficient multiple intestinal neoplasia mice by a specific cyclooxygenase-2 inhibitor and by a dual cyclooxygenase-1/2 inhibitor.
    Lal G; Ash C; Hay K; Redston M; Kwong E; Hancock B; Mak T; Kargman S; Evans JF; Gallinger S
    Cancer Res; 2001 Aug; 61(16):6131-6. PubMed ID: 11507063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute changes in colonic PGE
    Yun C; Dashwood WM; Li L; Yin T; Ulusan AM; Shatzer K; Gao S; Ruan KH; Hu M
    Inflamm Res; 2020 Jan; 69(1):131-137. PubMed ID: 31797003
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selective inhibition of cyclooxygenase-2 suppresses the growth of pancreatic cancer cells in vitro and in vivo.
    Xu XF; Xie CG; Wang XP; Liu J; Yu YC; Hu HL; Guo CY
    Tohoku J Exp Med; 2008 Jun; 215(2):149-57. PubMed ID: 18577844
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design, synthesis and biological evaluation of novel ferrocene-pyrazole derivatives containing nitric oxide donors as COX-2 inhibitors for cancer therapy.
    Ren SZ; Wang ZC; Zhu D; Zhu XH; Shen FQ; Wu SY; Chen JJ; Xu C; Zhu HL
    Eur J Med Chem; 2018 Sep; 157():909-924. PubMed ID: 30149323
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel dual cyclooxygenase and lipoxygenase inhibitors targeting hyaluronan-CD44v6 pathway and inducing cytotoxicity in colon cancer cells.
    Misra S; Ghatak S; Patil N; Dandawate P; Ambike V; Adsule S; Unni D; Venkateswara Swamy K; Padhye S
    Bioorg Med Chem; 2013 May; 21(9):2551-9. PubMed ID: 23517721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design and biological evaluation of novel hybrids of 1, 5-diarylpyrazole and Chrysin for selective COX-2 inhibition.
    Ren SZ; Wang ZC; Zhu XH; Zhu D; Li Z; Shen FQ; Duan YT; Cao H; Zhao J; Zhu HL
    Bioorg Med Chem; 2018 Aug; 26(14):4264-4275. PubMed ID: 30031652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.